U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07375290) titled 'Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors' on Nov. 12, 2025.
Brief Summary: The purpose of this pilot study is to investigate the safety and preliminarily assess efficacy of early intervention with zoledronate in high risk pediatric hematopoietic stem cell transplantation (HSCT) patients to prevent the development of bone disease and fractures and reduce potential pain and suffering.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Hematopoietic Stem Cell Transplantation
Intervention:
DRUG: Zoledronate
Zoledronate is in the class of drugs entit...